← Leaderboards
Vincent Robert Bonagura
Feinstein Institute For Medical Research
$5,873,561
Attributed
$5,873,561
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $932K · FY2006–17$1M$750K$500K$250K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
Funding mix
By agency
NIH$5,873,561 · 3
By mechanism
R01$4,526,852 · 1
T32$757,634 · 1
R21$589,075 · 1
Top collaborators
No co-investigators on record.
Most similar at Feinstein Institute For Medical Research
Same institution · by research overlap
- Alexandra Vitko Lucs$146,178
- Betty Diamond$68,537,262
- Richard Furie$3,392
Others in their field
Top investigators on “Keratinocyte”
- David Heimbrook · Leidos Biomedical Research, Inc.$31,285,017
- Kathleen Janee Green · Northwestern University$26,824,381
- Elaine Fuchs · University Of Chicago$24,033,644
- Gian Paolo Dotto · Massachusetts General Hospital$19,822,465
- Richard L Gallo · University Of California, San Diego$19,668,478
- Pierre Coulombe · Johns Hopkins University$19,316,020
Research focus
KeratinocyteRecurrenceOperative Surgical ProceduresLangerhans CellQuality Of LifeRespiratoryPapillomaChemokineResponseCytokineHuman Papilloma Virus InfectionHuman Papillomavirus 6ImmuneBenignHuman PapillomavirusPreventMortality Vital StatisticsMorbidity - Disease RateTumorChronicImmune FunctionCelecoxibImmune ResponseGrowth
Grant awards (18)
HPV-Specific, Immune Suppression in Patients with RRP$421,250
R01 · FY2017 · DE · contact PI
HPV-Specific, Immune Suppression in Patients with RRP$421,250
R01 · FY2016 · DE · contact PI
HPV-Specific, Immune Suppression in Patients with RRP$421,250
R01 · FY2015 · DE · contact PI
HPV-Specific, Immune Suppression in Patients with RRP$421,250
R01 · FY2014 · DE · contact PI
Reprogramming Host Immune Responses to Cure or Control Persistent HPV Infection$278,192
R21 · FY2014 · AI · contact PI
HPV-Specific, Immune Suppression in Patients with RRP$421,250
R01 · FY2013 · DE · contact PI
Reprogramming Host Immune Responses to Cure or Control Persistent HPV Infection$227,475
R21 · FY2013 · AI · contact PI
Immunology Physician Scientist$199,854
T32 · FY2013 · AI · contact PI
Reprogramming Host Immune Responses to Cure or Control Persistent HPV Infection$83,408
R21 · FY2013 · AI · contact PI
Immunology Physician Scientist$190,593
T32 · FY2012 · AI · contact PI
Immunology Physician Scientist$178,418
T32 · FY2011 · AI · contact PI
HPV-Specific, Immune Suppression in Patients with RRP$499,178
R01 · FY2010 · DE · contact PI
Immunology Physician Scientist$126,874
T32 · FY2010 · AI · contact PI
HPV-Specific, Immune Suppression in Patients with RRP$492,730
R01 · FY2009 · DE · contact PI
Immunology Physician Scientist$61,895
T32 · FY2009 · AI · contact PI
HPV-Specific, Immune Suppression in Patients with RRP$481,572
R01 · FY2008 · DE · contact PI
HPV-Specific, Immune Suppression in Patients with RRP$473,592
R01 · FY2007 · DE · contact PI
HPV-Specific, Immune Suppression in Patients with RRP$473,530
R01 · FY2006 · DE · contact PI